MCKENZIE CARTER: Open Payments
NPI 1336823715 · CRANSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 38 payments from 13 companies in 2025. Trend: 2023 $235 · 2024 $536 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $206 |
| AstraZeneca Pharmaceuticals LP | 8 | $190 |
| Novo Nordisk Inc | 4 | $106 |
| Lilly USA, LLC | 2 | $57 |
| Amgen Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Exact Sciences Corporation | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
Products named: VRAYLAR, FARXIGA, BREZTRI, Wegovy, MOUNJARO, UBRELVY, Auvelity, Cologuard Collection Kit.
Industry payments across RI — which companies pay providers there.
